Eli Lilly and Alchemab Therapeutics have partnered to develop new therapies for amyotrophic lateral sclerosis (ALS). The ...

When a renowned Israeli TV journalist lost his ability to speak clearly because of ALS, he thought his career might be over.

When a renowned Israeli TV journalist lost his ability to speak clearly because of ALS, he thought his career might be over.

When he was 25, he learned that he had multiple sclerosis. He coped with the disease throughout a long career at several ...

The voice of Israeli journalist Moshe Nussbaum has been revived using artificial intelligence after he was diagnosed with ALS.

The following is a summary of “Education moderates the association between motor involvement and executive status in ALS,” published in the December 2024 issue of Neurology by Aiello et al.

Synchron announced today that it expanded its partnership with Team Gleason to raise awareness for its brain-computer ...

Denali Therapeutics said on Monday its experimental drug failed to meet the main goal of a mid-to-late stage trial involving patients with amyotrophic lateral sclerosis (ALS), a fatal ...

A study of human brain organoids suggested a complex relationship between herpes simplex virus 1 infection and tau, ...

In studies by Massachusetts General Hospital, the AbbVie-Calico collaborative drug and Denali Therapeutics' own drug failed to meet endpoints for treating amyotrophic lateral sclerosis, more widely ...

Primary endpoint of overall function (ALSFRS-R) and survival, and key secondary endpoints of muscle strength and respiratory function, were not ...

Stephen Hawking Left a Serious Warning to Humanity About the Dangers of Artificial Intelligence Before His Death Stephen ...